Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study — Gabriella Sozzi (2014) | RDL Network
Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
Article 2014 en
Authors
GS
Gabriella Sozzi
MB
Mattia Boeri
MR
Marta Rossi
Abstract
1 min read
This large validation study indicates that MSC has predictive, diagnostic, and prognostic value and could reduce the false-positive rate of LDCT, thus improving the efficacy of lung cancer screening.
Stefano Sestini, Mattia Boeri, Alfonso Marchianò, Giuseppe Pelosi, Carlotta Galeone, Nicola Sverzellati, Carlo La Vecchia, Gabriella Sozzi, Ugo Pastorino
Maurizio Infante, Stefano Sestini, Carlotta Galeone, Alfonso Marchianò, Romano Fabio Lutman, Enzo Angeli, Giuseppina Calareso, Giuseppe Pelosi, Gabriella Sozzi, Mario Silva, Nicola Sverzellati, Silvio Cavuto, Carlo La Vecchia, Armando Santoro, Marco Alloisio, Ugo Pastorino
Discussion(0)
No comments yet. Be the first to comment.